An inflammatory mediator, prostaglandin e2, in colorectal cancer

Dingzhi Wang, Raymond N. Dubois

    Research output: Contribution to journalReview articlepeer-review

    90 Scopus citations


    It is widely accepted that intake of dietary fats and chronic inflammation are risk factors for developing colorectal cancer. Arachidonic acid is a major component of animal fats, and the bioactive lipids produced from this substrate play critical roles in a variety of biologic processes, including cancer. Cyclooxygenase-derived prostaglandin E2 is a known proinflammatory lipid mediator that promotes tumor progression. Metabolism of arachidonic acid by the cyclooxygenase pathway provides one mechanism for the contribution of dietary fats and chronic inflammation to carcinogenesis. In this review, we highlight recent advances in our understanding of how a proinflammatory mediator prostaglandin E2 promotes colorectal cancer immune evasion. These findings may provide a rationale for the development of new therapeutic approaches to subvert tumor-induced immunosuppression.

    Original languageEnglish (US)
    Pages (from-to)502-510
    Number of pages9
    JournalCancer Journal (United States)
    Issue number6
    StatePublished - Nov 2013


    • Colorectal cancer
    • Cyclooxygenase-Derived Prostaglandin E (Pge)
    • Risk Factors
    • Tumor-Induced Immunosuppression

    ASJC Scopus subject areas

    • Oncology
    • Cancer Research


    Dive into the research topics of 'An inflammatory mediator, prostaglandin e2, in colorectal cancer'. Together they form a unique fingerprint.

    Cite this